Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature [5]

Journal of Medical Microbiology

Volumn 56, Issue 7, 2007, Pages 1003-1004

  Agrawal, D ^a,d   Patterson, T F ^b   Rinaldi, M G ^b   Revankar, S G ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC SENSITIVITY; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA TROPICALIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCUBATION TEMPERATURE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; PHENOTYPE; TEMPERATURE;

EID: 34447255859     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47168-0     Document Type: Letter

References (7)

1. CLSI (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts, approved standard, 2nd edn, M27-A2. Wayne, PA: Clinical and Laboratory Standards Institute.
2. Lee, M. K., Williams, L. E., Warnock, D. W. & Arthington-Skaggs, B. A. (2004). Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 53, 217-224.
3. Marr, K. A., Rustad, T. R., Rex, J. H. & White, T. C. (1999). The trailing end point phenotype in antifungal susceptibility testing is pH dependent. Antimicrob Agents Chemother 43, 1383-1386.
4. Pfaller, M. A. & Diekema, D. J. (2004). Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 10 (Suppl. 1), 11-23.
5. Revankar, S. G., Kirkpatrick, W. R., McAtee, R. K., Fothergill, A. W., Redding, S. W., Rinaldi, M. G. & Patterson, T. F. (1998). Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards Method. J Clin Microbiol 36, 153-156.
6. Rex, J. H., Nelson, P. W., Paetznick, V. L., Lozano-Chiu, M., Espinel-Ingroff, A. & Anaissie, E. J. (1998). Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob Agents Chemother 42, 129-134.
7. Sanglard, D., Ischer, F., Marchetti, O., Entenza, J. & Bille, J. (2003). Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48, 959-976.